Elizabeth Helen Horn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Elizabeth Helen Horn has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Anthony C. Redmond
Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM) University of Leeds Leeds UK
1 shared publication- Bob Wong
College of Nursing, University of Utah, Salt Lake City, USA
1 shared publication - Charles Percy
University Hospitals Birmingham NHS Foundation Trust Birmingham UK
1 shared publication David Hopper
Newcastle Comprehensive Care Haemophilia Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK
1 shared publicationDeepan Gosrani
Cardiff Comprehensive Care Haemophilia Centre, University Hospital of Wales, Cardiff, UK
1 shared publication- Gerald G.. Krueger
J.A. Walsh, MD, C. Carroll, MSc, M. Milliken, MD, MPH, K. Callis Duffin, MD, G.G. Krueger, MD, School of Medicine, University of Utah, Salt Lake City, Utah, USA
1 shared publication
Latest Publications
- 27 June 2025
- Published by BMJ in Emergency Medicine Journal
- Vol. 43 (1) , 49-54
Management of haemophilia and heritable bleeding disorders in the ED
This practice review addresses the management of haemophilia and heritable bleeding disorders in the ED. These disorders are uncommonly encountered by the emergency physician, but prompt and appropriate management is critical to ensure good outcomes. This practice review describes the principles of emergency care for people with bleeding disorders, with an emphasis on a pragmatic clinical approach, and provides examples of challenging emergencies.
- 27 June 2025
- Published by BMJ in Emergency Medicine Journal
- Vol. 43 (1) , 49-54
Management of haemophilia and heritable bleeding disorders in the ED
This practice review addresses the management of haemophilia and heritable bleeding disorders in the ED. These disorders are uncommonly encountered by the emergency physician, but prompt and appropriate management is critical to ensure good outcomes. This practice review describes the principles of emergency care for people with bleeding disorders, with an emphasis on a pragmatic clinical approach, and provides examples of challenging emergencies.
- Open Access
- 18 December 2022
- Published by Wiley in Haemophilia
- Vol. 29 (2) , 600-607
The impact of ankle haemarthropathy in patients with moderate haemophilia
IntroductionModerate haemophilia has traditionally been associated with less complications than severe haemophilia. Changes in treatment recommendations have highlighted the burden of moderate haemophilia with a subset of patients with a severe bleeding phenotype. The ankle joint is disproportionally affected by ankle haemarthropathy however the impact has not been evaluated in moderate haemophilia, nor the effect on health related quality of life (HRQoL) or foot and ankle outcomes. AimsTo establish the impact of ankle haemarthropathy in patients with moderate haemophilia. MethodsA multicentre questionnaire study recruited patients from 11 haemophilia centres in England, Scotland and Wales. The HAEMO-QoL-A and Manchester-Oxford foot and ankle questionnaire (MOXFQ) with total and domain scores measured impact. Measures of pain and ankle haemophilia joint health (HJHS) scores were also collected. ResultsTwenty-nine participants were recruited. HAEMO-QoL A mean (SD) total scores of 10.8 (5.2) of 100 (best health) and foot and ankle specific MOXFQ total scores of 45.5 (24.7) above zero (best outcome) indicate poor HRQoL and foot and ankle outcomes. Average ankle pain over past 6 months of (0-10) 5.5 (SD2.5) was reported and median (IQR) ankle HJHS of 3.0 (1;12.5) to 4.5 (0;9.5) for the left and right ankles. ConclusionHRQoL and foot and ankle specific outcomes are poor in patients with moderate haemophilia and ankle haemarthropathy, driven by chronic levels of ankle joint pain. Despite moderate haemophilia being considered less affected by haemarthrosis and haemarthropathy, patients with a bleeding or haemarthropathy phenotype are clinically similar to patients with severe haemophilia A.
- 18 December 2022
- Published by Wiley in Haemophilia
- Vol. 29 (2) , 600-607
Open AccessThe impact of ankle haemarthropathy in patients with moderate haemophilia
IntroductionModerate haemophilia has traditionally been associated with less complications than severe haemophilia. Changes in treatment recommendations have highlighted the burden of moderate haemophilia with a subset of patients with a severe bleeding phenotype. The ankle joint is disproportionally affected by ankle haemarthropathy however the impact has not been evaluated in moderate haemophilia, nor the effect on health related quality of life (HRQoL) or foot and ankle outcomes. AimsTo establish the impact of ankle haemarthropathy in patients with moderate haemophilia. MethodsA multicentre questionnaire study recruited patients from 11 haemophilia centres in England, Scotland and Wales. The HAEMO-QoL-A and Manchester-Oxford foot and ankle questionnaire (MOXFQ) with total and domain scores measured impact. Measures of pain and ankle haemophilia joint health (HJHS) scores were also collected. ResultsTwenty-nine participants were recruited. HAEMO-QoL A mean (SD) total scores of 10.8 (5.2) of 100 (best health) and foot and ankle specific MOXFQ total scores of 45.5 (24.7) above zero (best outcome) indicate poor HRQoL and foot and ankle outcomes. Average ankle pain over past 6 months of (0-10) 5.5 (SD2.5) was reported and median (IQR) ankle HJHS of 3.0 (1;12.5) to 4.5 (0;9.5) for the left and right ankles. ConclusionHRQoL and foot and ankle specific outcomes are poor in patients with moderate haemophilia and ankle haemarthropathy, driven by chronic levels of ankle joint pain. Despite moderate haemophilia being considered less affected by haemarthrosis and haemarthropathy, patients with a bleeding or haemarthropathy phenotype are clinically similar to patients with severe haemophilia A.
- 1 April 2009
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 60 (4) , 604-608
Psoriatic arthritis is a strong predictor of sleep interference in patients with psoriasis
- 1 April 2009
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 60 (4) , 604-608
Psoriatic arthritis is a strong predictor of sleep interference in patients with psoriasis